Stockreport

AGC Biologics Partners with ATUM to Accelerate Timelines for Cell Line Development

AGC INC UNSP/ADR  (ASGLY) 
PDF New offering provides drug developers with flexible and powerful cell line development options for monoclonal antibodies, multi-specific and complex molecules SEATTLE [Read more]